Catalyst

Slingshot members are tracking this event:

Kite Pharma (KITE) Research with National Cancer Institute Evaluating T-Cell Therapy in KRAS Mutant Metastatic Colorectal Cancer Published in New England Journal of Medicine

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
KITE

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 12, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords National Institutes Of Health, T-cell Therapy, Kras Mutant Metastatic Coloractal Cancer, New England Journal Of Medicine, National Cancer Institute